Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129027) titled 'Clinical Study on the Diagnosis and Treatment of Patients with Advanced Solid Tumors Using ¹77Lu-FAPI' on July 29.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Affiliated Hospital of Inner Mongolia Medical University
Condition:
Advanced malignant solid tumours confirmed by histological or cytological examination
Intervention:
Experimental Group:Treatment with 177Lu-FAPI injection is administered using a dose-escalation protocol
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-07-30
Target Sample Size: Experimental Group:12;
Countries ...